James Daniel Kish - Oct 31, 2021 Form 3 Insider Report for Sunshine Biopharma, Inc (SBFM)

Role
Director
Signature
James Daniel Kish
Stock symbol
SBFM
Transactions as of
Oct 31, 2021
Transactions value $
$0
Form type
3
Date filed
12/14/2021, 12:20 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SBFM Common Stock 287K Oct 31, 2021 Direct
holding SBFM Common Stock 2.5K Oct 31, 2021 Held in the name of Reporting Person's Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.